Stay updated with breaking news from Colleen Loo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Subcutaneous ketamine is a practical, safe, and highly effective way to administer the drug for treatment-resistant depression, results of a randomized controlled phase 3 trial show.
A new study conducted in Australia and New Zealand found that a low-cost version of ketamine helped 20% of participants with severe depression achieve total remission from their symptoms.
Generic ketamine could cost as little as $5, which is significantly lower than the $800 per dose for the currently available S-ketamine nasal spray.
TUESDAY, July 18, 2023 (HealthDay News) -- Dr. Dan Iosifescu’s patient had a history of depression and had done well for a number of years. But the illness returned with
James Cameron and his friend and mentor Dr. Joe MacInnis discuss deep sea exploration, hosted by CTV's Vassy Kapelos.